Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death COGNIS(TM) CRT-D and TELIGEN(TM) ICD represent entirely new platforms NATICK, Mass., May 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and...
[read full story]